LICN Lichen International Ltd Annual reports only
Services-Management Consulting Services · Nasdaq · SEC CIK 1876766 · Fiscal year ends 12/31
Financial factors as of 2022-12-31 (FY2022), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-1.4%
TTM net income YoY-7.6%
TTM EPS YoY18,189.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin59.7%
Operating margin31.5%
Net margin23.1%
FCF margin26.1%
EBITDA margin33.4%
Returns
ROE20.1%
ROA17.5%
ROIC (approx.)40.3%
Asset turnover0.76x
Leverage & solvency
Liabilities / assets11.6%
Debt / equity0.00x
Current ratio5.21x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.38x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue5.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $809,000 | $0 |
| Cost of revenue | $15.38M | $15.80M |
| Gross profit | $9.14M | $25.67M |
| SG&A expense | $12.91M | $17.70M |
| Operating income | -$18.07M | -$4.55M |
| Pretax income | -$21.79M | -$4.17M |
| Income tax | $0 | $1.95M |
| Net income | -$21.96M | -$6.14M |
| EBITDA | -$17.51M | -$3.86M |
| EPS (basic) | -4.11 | -34.79 |
| EPS (diluted) | -4.11 | -34.79 |
| Weighted avg. shares (diluted) | 5.30M | 175,897 |
| Balance sheet | ||
| Cash & equivalents | $26.91M | $26.71M |
| Inventory | $0 | $67,000 |
| Current assets | $36.17M | $34.01M |
| PP&E, net | $7.04M | $13.69M |
| Goodwill | $791,000 | $4.45M |
| Intangibles | $8.09M | $11.05M |
| Total assets | $75.57M | $79.84M |
| Current liabilities | $4.68M | $4.27M |
| Total liabilities | $5.02M | $4.28M |
| Shareholders' equity | $70.55M | $73.18M |
| Cash flow statement | ||
| Operating cash flow | -$17.85M | -$5.57M |
| Capital expenditure | $0 | $36,000 |
| Free cash flow | -$17.85M | -$5.61M |
| Investing cash flow | -$5.48M | -$9.89M |
| Financing cash flow | $23.61M | $13.09M |
| Depreciation & amortization | $561,000 | $691,000 |
| Stock-based compensation | $314,000 | $3.41M |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.